Draft:Dr. Milad Alucozai
| Submission declined on 10 December 2023 by Qcne (talk). This submission does not appear to be written in the formal tone expected of an encyclopedia article. Entries should be written from a neutral point of view, and should refer to a range of independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 26 November 2023 by WikiOriginal-9 (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. | |
| Submission declined on 5 November 2023 by Theroadislong (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. | |
Comment: Language is inappropriate with WP:PEACOCK language. Qcne (talk) 18:31, 10 December 2023 (UTC)
- Comment: no sources? Theroadislong (talk) 02:59, 5 November 2023 (UTC)
Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine. With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard University.[1][2][3]
Early Life and Education[edit]
Alucozai was born in Kabul, Afghanistan, the oldest of four siblings. He is part of the Alakozai dynasty. He grew up loving bad weather because it meant that he was less likely to be killed by a rocket fire. After his neighborhood was caught up in the war, his family fled to a refugee camp in Pakistan. Eventually, they came to the US to start over with less than a dollar to their name. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.[4][5][6][7]
Career[edit]
Neuroscientist and Serial Entrepreneur[edit]
He started his career in translational neuroscience and multiphysics laboratories, including the Birck Nanotechnology Center. He eventually transitioned into founding roles at two biotech startups and later Chief Business Officer. At Accenture, Alucozai directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies.[8][9]
Active Biotech Investor and Advisor[edit]
Currently, Alucozai is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms.[10] He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions. Alucozai serves as a Fellow in Healthcare Engineering at the Regenstrief Center.[11] In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine.[2]
Honors[edit]
Alucozai was selected to the CGI University Honor Roll.[12]
- ^ "Milad Alucozai, MSc, MPH, DrPH". Wyss Institute. 2023-07-13. Retrieved 2023-11-26.
- ^ a b "Milad Alucozai". Creative Destruction Lab. Retrieved 2023-11-26.
- ^ "Entrepreneurial advice from our hive mind". Wyss Institute. 2023-11-15. Retrieved 2023-11-26.
- ^ Primo, Valentina (2021-09-16). "7 Inspiring Afghan Refugee Entrepreneurs Who Show The Innovative Face of Afghanistan - Startups Without Borders". Retrieved 2023-11-26.
- ^ "School of Aeronautics and Astronautics assistant researcher Milad Alucozai named Purdue's first Mitchell Scholarship winner". School of Aeronautics and Astronautics - Purdue University. Retrieved 2023-11-26.
- ^ "Milad Alucozai - John Martinson Honors College - Purdue University". www.purdue.edu. Retrieved 2023-11-26.
- ^ Manager, ELIANA YU Online (2015-03-02). "Alumnus, scholar, Clinton Global mentor offers students networking opportunity". Purdue Exponent. Retrieved 2023-11-26.
- ^ "Go from Scientist to Successful Entrepreneur with Dr. Milad Alucozai, BoxOne Ventures - Research Institute of the McGill University Health Centre - RI-MUHC". Research Institute of the McGill University Health Centre. Retrieved 2023-12-10.
- ^ "Milad Alucozai's Investing Profile - BoxOne Ventures Investor | Signal". Signal: where top founders find and get introduced to the right investors. Retrieved 2023-11-26.
- ^ "Top 50 Biotech Angel Investors in United States — Nov 2023". Shizune. Retrieved 2023-11-26.
- ^ Today, Purdue. "Purdue entrepreneurship fellows assist health care technology acceleration". www.purdue.edu. Retrieved 2023-11-26.
- ^ Service, Purdue News. "Appointments, honors and activities". www.purdue.edu. Retrieved 2023-12-10.